Billionaire David Tepper Has 40% of His Portfolio Invested in These 4 Growth Stocks

In this video, I will review David Tepper’s Appaloosa Management portfolio and talk about the four stocks that comprise 40% of the portfolio. *Stock prices used were from the trading day of April 12, 2024. The video was published on April 15, 2024. Should you invest $1,000 in Nvidia right now? Before you buy stock

Markets shrug off risks of a wider Mideast war involving Israel and Iran. Why?

masterSergeant/iStock via Getty Images The market reaction to Iran’s unprecedented strike on Israel has been contained so far, as the region’s path to an all-out war seems to be contained (so far). More than 170 drones, as well as 150 cruise and ballistic missiles, were launched on Saturday by the Islamic Republic, though 99% of

Israel’s Netanyahu vows victory after Iran strikes, fears of wider conflict grow By Reuters

By Dan Williams, Parisa Hafezi and Jeff Mason JERUSALEM (Reuters) -Top Iranian commanders warned Israel on Sunday that the country would face a bigger attack if it retaliates against overnight drone and missile strikes, adding that Washington has been told not to back any military action from its ally. “Our response will be much larger

No evidence Ozempic and Wegovy raise risk of self harm, EU regulators said

Drug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal thoughts or actions. The European Medicines Agency regulatory committee announced the results of its review on Friday. It’s the latest group to conclude there’s no known tie between a new class

China has strong fundamentals, businesses should expand: Gan Kim Yong

Businesses should continue to focus on China and explore opportunities to expand their presence in the world’s second-largest economy, Singapore Minister for Trade and Industry Gan Kim Yong said Friday. China had briefly entered deflation territory late last year, and is still struggling with a debt-laden real estate sector. Ratings agency Fitch cut its outlook

How AI is helping to prevent future power cuts

“Since the storm we built over five gigawatts of battery storage capacity in Texas in three years, which is really an incredible pace,” says Dr Michael Webber, professor of energy resources at the University of Texas at Austin. That much energy, he says, is about “four large nuclear power plants”. Source link

Next and Frasers Group vying to acquire troubled Ted Baker

Next and Frasers Group have emerged as potential buyers for Ted Baker’s European retail business, signalling interest in salvaging the fashion label after its recent collapse into administration. Both companies are in discussions with administrators at Teneo Advisory to explore the possibility of acquiring all or parts of Ted Baker’s operations. The collapse of No

Durendal Resources Unveils TerraDX: Revolutionizing the Discovery of Critical Metals with Cutting-Edge Technology

This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Breadcrumb Trail Links GlobeNewswire Author of the article: Published Apr 08, 2024  •  2 minute read You can save this

1 Beaten-Down Stock That Could Make You Richer

About a half-billion adults in the world have diabetes. This chronic health condition causes severe hardships to patients and contributes substantially to healthcare costs. It’s no wonder that many companies continue developing innovative products to help diabetes patients manage the disease. One of them is Tandem Diabetes Care (NASDAQ: TNDM), a medical device specialist that

J&J wins FDA nod for Carvykti label expansion (NYSE:JNJ)

Grandbrothers Johnson & Johnson (NYSE:JNJ) has received FDA approval to expand the current labeling for its CAR-T cell therapy, Carvykti, developed in partnership with Legend Biotech (NASDAQ:LEGN), to include adults with the blood cancer multiple myeloma in an earlier-line setting. Accordingly, the treatment-targeting B-cell maturation antigen (BCMA) will be indicated in the U.S. for adults

Popular Posts
Featured Posts
Recent Posts
Popular in Bitcoin
Trending Posts